Transformative Biotech Acquires Summit Biolabs’ Direct-to-PCR Technologies
NEW YORK – Boulder, Colorado-based Transformative Biotech announced on Thursday that it has acquired extraction-free, direct-to-PCR technologies...
Transformative Biotech Purchases Direct-to-PCR Technologies From Summit Biolabs (Full text as published in PR Newswire)
Market-proven technologies in this intellectual property transaction offers many advantages over traditional PCR testing. BOULDER, Colo., May 18,...
Formation of Transformative Biotech, LLC
Transformative Biotech Formed to Deploy Transformative Direct-to-PCR technologies Transformative Biotech created to deploy direct-to-PCR technologies in the fields of...
Summit Biolabs Passes Next COVID-19 Testing Milestone.
AURORA, Colo., Jan. 31, 2022 -- Summit Biolabs, a commercial-stage molecular diagnostics company harnessing the power of direct-to-PCR...
Summit Biolabs Passes Significant Milestones
Summit Biolabs Passes Significant Milestones Dear Investors & Friends of Summit Biolabs: We are pleased to announce that Summit...
Summit Biolabs Announces Certification of Compliance to Perform Testing under CLIA
Aurora, Colorado, June 25, 2021 - - Summit Biolabs, a commercial stage molecular diagnostics companypioneering saliva liquid-biopsy...
Summit Receives Investment from U. of Colorado Anschutz Medical Campus CDI Fund
University of Colorado Anschutz Medical Campus, Chancellor Discovery Innovation Fund (CDI Fund) Finalizes Investment in Summit Biolabs AURORA,...
CU Innovations 2020 Annual Report
20201109 CU Innovations Annual Report Shi-Long Lu
